Temokem 250mg Injection
Marketer
Alkem Laboratories Ltd
Salt Composition
Temozolomide (250mg)
Overview Temokem 250mg Injection
Oncaspar 250mg Injection is indicated for managing a particular form of brain malignancy. It's employed to address recurrent or progressive brain tumors following conventional therapies. Other applications may be determined by your physician. Administration is solely by a healthcare professional; self-administration is strictly prohibited. Dosage and frequency are physician-determined, adjusted based on disease severity. Therapeutic effects may take weeks or months to manifest; discontinuation requires medical consultation. Frequent adverse reactions encompass nausea, vomiting, bowel irregularity, cephalgia, and lassitude. Myelosuppression, increasing infection risk, is possible; regular hematological monitoring, along with renal, hepatic, and cardiac function assessments, are mandatory. Pre-treatment disclosure of bleeding disorders, hepatic or renal impairment, and concomitant anti-infective medications is crucial. Drug interactions are possible; complete medication disclosure is essential. This medication is contraindicated during gestation and lactation. Reliable contraception is vital for both partners throughout treatment to prevent conception.
Uses of Temokem 250mg Injection
Neoplasm of the cerebrum
Major Benefits of Temokem 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Temokem 250mg Injection:
- Memory loss
- Rash
- Headache
- Dizziness
- Convulsion
- Coordination disorder
- Insomnia (difficulty in sleeping)
- Vomiting
- Weakness
- Nausea
- Loss of appetite
- Hair loss
- Fatigue
- Fever
- Diarrhea
- Constipation
- Hemiparesis (weakness on one side of the body)
- Viral infection
How to use Temokem 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Temokem 250mg Injection works:
Oncaspar 250mg Injection, an anticancer agent, penetrates brain tissue to disrupt the DNA and RNA of malignant cells, thereby inhibiting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Temokem 250mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Temokem 250mg Injection during pregnancy carries established risks to fetal development and is therefore inadvisable. Nevertheless, a physician might exceptionally prescribe it in emergencies where the potential advantages significantly outweigh the known hazards. Always seek medical counsel.
Breast feedingUNSAFE
Administering Temokem 250mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administration of Temokem 250mg Injection can lead to reduced alertness, visual impairment, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneySAFE IF PRESCRIBED
The use of Temokem 250mg Injection in patients with kidney impairment is likely safe, with preliminary evidence indicating dose modification may be unnecessary. However, physician consultation is recommended. For individuals with severe kidney disease, Temokem 250mg Injection should be administered with caution.
LiverCAUTION
Caution is advised when administering Temokem 250mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Seek medical counsel. Data regarding Temokem 250mg Injection use in such patients is limited. Dosage alteration is not suggested for those with mild or moderate liver dysfunction.
What if you forget to take Temokem 250mg Injection :
Should you forget a Temokem 250mg Injection, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Temokem 250mg Injection
| Label | Value |
|---|---|
| Pharmacological Category | Carmustine analog |
| Potential for Dependence | None. |
| Medication Classification | Cancer therapeutics |
| Mechanism of Action | DNA-reactive chemotherapeutic |
3,018 People bought this recently